4-Methyl-2,5-methoxyphenylcyclopropylamine
 | |
 | |
| Names | |
|---|---|
| IUPAC name
2-(2,5-Dimethoxy-4-methylphenyl)cyclopropanamine | |
| Identifiers | |
69854-49-5  | |
| ChEMBL | ChEMBL13530  |
| ChemSpider | 2285590 |
| Jmol interactive 3D | Image |
| PubChem | 3017965 |
| |
| |
| Properties | |
| C12H17NO2 | |
| Molar mass | 207.27 g/mol |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| verify (what is ?) | |
| Infobox references | |
DMCPA, or 4-methyl-2,5-methoxyphenylcyclopropylamine, is a lesser-known psychedelic drug and a substituted amphetamine. DMCPA was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 15–20 mg, and the duration is listed as 4–8 hours. DMCPA produces open-eye visuals, anorexia, and psychedelic dreams. Shulgin gives it a +++ on the Shulgin Rating Scale.
Pharmacology
Very little data exists about the pharmacological properties, metabolism, and toxicity of DMCPA.
See also
External links
This article is issued from Wikipedia - version of the Tuesday, July 07, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.